CLINICAL AUDIT Drug Prescribing for ADHD in Children

Slides:



Advertisements
Similar presentations
Implementing NICE guidance
Advertisements

Attention deficit hyperactivity disorder Implementing NICE guidance 2008 NICE clinical guideline 72.
SPAIIN Where are we now?. Key concepts in clinical networks Equitable Efficient High quality Locally delivered Patient/Carer involvement ‘designed to.
Young People in Secure Settings- Feedback Dr Inyang Takon Consultant Paediatrician QEII Hospital, Welwyn Garden City, Herts.
Mental Health: assessment and rehabilitation Dr Doreen Miller FRCP FFOM Managing Partner Miller Health Management.
2012 UPDATE. What guidelines do we have available to follow for asthma 1) Asthma GP monitoring Guideline 2) Asthma Diagnosis Guideline 3) Acute asthma.
Retinopathy of Prematurity Neonatal Audit 2010 Dr Anjan Bhaduri Mr Syed Ali Dr Gopal Krishana Singh.
1 KEEP YOUR EYES OPEN! Untreated co-morbidities in adults with Epilepsy and Learning Disability Authors; Flinton L, Pashley S, Lewington E.
Lambeth Specialist Healthy Weight Project
Developing a National Paediatric Diabetes Plan: What are the key issues for education? Dr. Sheridan Waldron HCP Education Lead for Children and Young people.
Improving the Quality of Physical Health Checks
Improving the Quality of Physical Health Checks Kate Dale, Mental/Physical Health Lead BDCT.
Tina Huang.  Aimed at people aged 40 – 74  Risk assessment and management programme to prevent or delay the onset of diabetes, heart and kidney disease.
Aim To assess the effectiveness of medical or surgical treatment in patients with sino-nasal disease who present to ENT outpatient clinics.
The ADHD Toolkit SECTION 1 Background to the concept of ADHD 1.
Pregnancy care in women with BMI>35 Dr S Sharma, Dr A Mahmud and Dr N Manheri-OthayothUniversity Hospital of Wales, Cardiff UK Pregnancy care in women.
Sudipta Sen 2 nd June 2015 INTEGRATED/COLLABORATIVE CARE IN ADHD MANAGEMENT.
Attention Deficit and Hyperkinetic Disorders in Children and Young People Dr. Derek Godfrey (GPR)
Impact of: a specialist wound clinic on patients who develop complex wounds post cardiac surgery Presented by: Penny Gowland ANP Pascaline Njoki Thanks.
© National Confidential Inquiry into Suicide and Homicide by People with Mental Illness. All rights reserved. Not to be reproduced in whole or in part.
M eaningful Quality Measures for Children with Behavioral Health Conditions Discussion with the NYS Conference of Local Mental Health Hygiene Directors.
Date of presentation Name of presenter UK IBD audit 3rd round Primary care questionnaire.
Practice Key Driver Diagram. Chapter Quality Network ADHD Project Jeff Epstein PhD CQN ADHD National Expert/CQN Data Analyst The mehealth Portal and CQN.
Use of mental health services by U.S. children, 2005* Gloria A. Simpson Robin A. Cohen Patricia N. Pastor Cynthia A. Reuben *Findings are based on the.
UK Renal Registry 15th Annual Report Figure 7.1. Median height z-scores for transplant patients
Audit of psychotropic medication prescribing in EMI nursing homes in Monmouthshire Dr Pauline Ruth Dr Rui Zheng Dr Arpita Chakraborty Dr Usman Mansoor.
Evidence-based practice guidelines: Chronic harms of substance use.
“Focusing on the Process” Jeff Schmidt MD.  Recommendation #1: Children ages 4-18 who present with academic underachievement, behavior problems or.
Hepatitis B screening and vaccination for Slovak Roma population in Sheffield. Age >16 1/Start standard schedule of hepatitis B vaccination if history.
Dr Sharma’s Practice Patient Participation Group 12 th March 2012.
NHS Health Check programme An opportunity to engage 15 million people to live well for longer Louise Cleaver National Programme Support Manager.
Peer Review for Paediatric Diabetes Ruth Bridgeman.
POMH-UK Topic 2e supplementary audit Screening for metabolic side effects of antipsychotic drugs in patients under the care of assertive outreach teams.
Prescribing antipsychotics for children and adolescents
Dept. Paediatrics, Leicester Royal Infirmary, Leicester
Prescribing for ADHD in children, adolescents and adults
Evidence-Based Resources
Attention-Deficit/Hyperactivity Disorder: What you need to know
Fracture Liaison Service Database
Family History Information Helps Inform Chronic Pain Treatment
Diabetes Clinical Audit- July/Aug 2014
clinical standards for health care information
Helping you prevent heart disease, stroke, diabetes and kidney disease
Title of the Change Project
The potential for pharmacists to manage young patients attending Emergency Departments - UK David Terry1,2, Chi Huynh1, Konstantinos Petridis3, Matt Aeillo4,
Opioids Aware A resource for patients and healthcare professionals to support prescribing of opioid medicines for pain.
A Single Centre Experience In Managing Anaphylaxis In The Emergency Department Iman Nasr1; Joanna Lukawska1,2; Runa Ali1; Ikram Nasr3; Jason Pott1; Tim.
“Medicines Reconciliation” Audit
Knowledge and Understanding
St Martins Healthcare Clinical Pathway
Quality improvement programme
HEDIS ® Measures & Tips: Behavioral Health
The mehealth Portal and CQN ADHD Measurement
Referring to the Memory Clinic
The Atrial Fibrillation Clinic in Llanelli
Management of Patients following a Myocardial Infarction in the Community Dr Anjali Kay GPST3, Dr Katharine Saxby GP Partner 6-8th October 2016 Introduction.
Health Home Program Services
City & Hackney CAMHS1, Tower Hamlets CAMHS2
ADHD & Autism.
Physical Health Assessment Clinic
Understanding growth and puberty using the RCPCH UK 2-18 growth charts
Price List Vet Appointments Consultation with Vet (15 minutes) £44.00
Principal recommendations
The Role of the Cardiovascular Nurse Alison de Vries
How will the NHS Long Term Plan work in our community?
Certified Community Behavioral Health Clinic
Certified Community Behavioral Health Clinics
Asthma Education for Families and HCPs
Hepatitis C Testing, Treatment, Care and Support
Presentation transcript:

CLINICAL AUDIT Drug Prescribing for ADHD in Children Dr S McVea (ST2 Paediatrics) Dr A Armstrong (Consultant Paediatrician)

INTRODUCTION Attention Deficit Hyperactivity Disorder A heterogeneous behavioural syndrome characterised by Hyperactivity Impulsivity Inattention Prevalence ≈ 3-5% M:F 2-4:1 Clinical diagnosis based on standardised questionnaires Management involves a combination of pharmacological and non pharmacological interventions Oxford Specialist Handbook: Community Paediatrics. Gada. 2012

AIM To identify areas of good practice and areas for improvement when prescribing medications to treat ADHD.

METHODOLOGY All children attending ADHD clinics in Holywood Arches during March 2013 were identified from clinic lists. Patient notes, PARIS entries & letters on Patient Centre were reviewed retrospectively. Standardized proforma used to collect data RCPsych POMH-UK Topic 13a: Prescribing for ADHD in children adolescence and adults.

STANDARD

STANDARD Prescribing Observatory for Mental Health (POMH-UK) Initiating drug treatment for ADHD (<1 year subgroup) Before starting drug treatment, children, adolescents and adults with ADHD should have a full pre- treatment assessment, including the following: heart rate and blood pressure (recorded as centile in children), height and weight (recorded on a growth chart in children), cardiovascular risk, substance misuse risk and Weight, heart rate and blood pressure measured within 3 months of starting treatment. Maintenance treatment (>1 year subgroup) In all patients, ADHD treatment should be reviewed at least annually, using standardised rating scales. Height and weight should be measured every 6 months in children and young people, and recorded on a growth chart Heart rate and BP should be measured every 3 months (recorded as centile in children)

RESULTS 38 patients attended ADHD clinic in March 2013 8 children excluded Notes unavailable / Insufficient detail on PARIS / Patient Centre (n=3) Non ADHD attendances (n=5) 30 patients included in audit

RESULTS Gender & Age Distribution M:F 2.75:1 Mean Age: 10y Median Age: 10y

RESULTS 24 (80%) had a diagnosis of ADHD Normal Connors 2 pts ADD diagnosed 2 pts Connors +ve in single setting 1 pt Awaiting result of Connors 1 pt N = 30

RESULTS Current Treatment 100% GP Prescribed N = 24

STANDARD Prescribing Observatory for Mental Health (POMH-UK) Initiating drug treatment for ADHD (<1 year subgroup) Before starting drug treatment, children, adolescents and adults with ADHD should have a full pre- treatment assessment, including the following: heart rate and blood pressure (recorded as centile in children), height and weight (recorded on a growth chart in children), cardiovascular risk, substance misuse risk and Weight, heart rate and blood pressure measured within 3 months of starting treatment. Maintenance treatment (>1 year subgroup) In all patients, ADHD treatment should be reviewed at least annually, using standardised rating scales. Height and weight should be measured every 6 months in children and young people, and recorded on a growth chart Heart rate and BP should be measured every 3 months (recorded as centile in children)

RESULTS Initiating Drug Treatment 7 patients identified had been started on treatment within 1 year Diagnosis made by Paediatrician in all cases All diagnoses were based on standardized rating scales Connors Rating Scale in all cases Input from parents and school in all cases. Treatment initiated by Paediatician in all cases N = 7

RESULTS Pre-Treatment Risk Assessment Growth Pre-treatment height and weight recorded 7 pts 100% Both plotted 6 pts 86% CVS Risk Assessment Pre-treatment BP recorded 6 pts 86% BP plotted 0 pts 0% Pre-treatment HR recorded 1 pt 14% HR plotted 0 pts 0% Cardiac examination 7 pts 100% Cardiac history 2 pts 29% Substance misuse risk assessment 0% 0% N = 7

RESULTS Non-Pharmacological Therapies Documented non pharmacological therapies offered to 6pts (86%) Parent training books Local parent training classes Anger management books Information leaflets given and documented in 4pts (57%) N = 7

RESULTS Post Initiation Monitoring 6 children initiated on Rx were started 3-12 months prior to audit. Height plotted within 3 months of initiation 3pts (50%) Weight plotted within 3 months of initiation 4pts (67%) BP measured within 3 months of initiation 5pts (83%) BP plotted 0 pts (0%) HR measured within 3 months of initiation 1 pt (17%) HR plotted 0 pts (0%) N = 6

Initiating drug treatment for ADHD Maintenance treatment STANDARD Initiating drug treatment for ADHD (<1 year subgroup) Before starting drug treatment, children, adolescents and adults with ADHD should have a full pre- treatment assessment, including the following: heart rate and blood pressure (recorded as centile in children), height and weight (recorded on a growth chart in children), cardiovascular risk, substance misuse risk and Weight, heart rate and blood pressure measured within 3 months of starting treatment. Maintenance treatment (>1 year subgroup) In all patients, ADHD treatment should be reviewed at least annually, using standardised rating scales. Height and weight should be measured every 6 months in children and young people, and recorded on a growth chart Heart rate and BP should be measured every 3 months (recorded as centile in children)

RESULTS Maintenance Treatment 15 patients identified had been on treatment for >1year Medication review within the preceding year 13pts 87% DNA appropriate review appointments 2pts 13% Standardized rating scale utilized to guide Rx 1pt 7% This was a r/v from another trust where Parents asked for 2nd opinion These 3 patients were excluded from further analysis

RESULTS Number of Reviews in 12 months Prior to Audit Number of Patients Number of Reviews N = 12

RESULTS Maintenance Therapy Height measured ≤6 monthly 6pts 50% Height plotted ≤6 monthly 2pts 17% Weight measured ≤6 monthly 6pts 50% Weight plotted ≤6 monthly 3pts 25% N = 12

RESULTS Maintenance Therapy BP measured ≤3 monthly 2pts 17% BP plotted ≤3 monthly 0pts 0% BP measured ≤6 monthly 6pts 50% BP plotted ≤6 monthly 0pts 0% HR was recorded in only one review N = 12

LIMITATIONS Retrospective Single center audited Results strongly influenced by standard of documentation Single center audited Limited subpopulation sizes

RECOMMENDATIONS Update current new patient proforma Formal CVS risk assessment section in PMH / FH Specific weight, height, BP and HR spaces in examination section with associated centile entry spaces Make BP and HR centiles easily accessible in clinic Specific substance misuse risk assessment section Update review proforma Make standard ADHD review more <yearly Workforce limitations GP to check parameters and send to lead paediatrician ? Issue annual repeat standardized questionnaires with appointment letter Staff education to increase awareness of current standards